Formally established by the institution in 2006 to address the growing demand for bioinformatics expertise at Mayo Clinic, the Bioinformatics Core Shared Resource (BIC) is a new shared resource of the Cancer Center. The mission of the Shared Resource is to assist Mayo Clinic Cancer Center (MCCC) investigators in leveraging intramural and extramural sources of biological information to promote discoveries that will impact patient care. To this end, the BIC offers a suite of services to support investigators with the manipulation, preprocessing, and interpretation of genomics, microarray, and proteomics data. These services include: sequence analysis and comparative genomics;gene and SNP selection for association studies;data parsing and formatting;gene ID conversion, biological pathway and networks analysis;data preprocessing;including quality control;and management and education regarding public and local databases and bioinformatics applications. BIC has assembled a team of 13 computer scientists and 12 bioinformatics experts who work collaboratively with biostatisticians to provide analytical support to investigators at all three Mayo campuses. NCI related goals for bioinformatics is assured by dedicated Shared Resource support for the evaluation and integration of caBIG projects into Mayo's infrastructure. BIC provides critical 'value-add'to MCCC investigators in providing (i) investigator support during planning and execution of high throughput experiments;(ii) development of bioinformatics tools and education programs;and (iii) infrastructure for experimental techniques and analytical methods validation, including quality control workflows for genotyping data, preprocessing workflows for gene expression profiles, validation of copy number variation, and high throughput sequencing;and platforms for data integration and mining. Over the past year, BIC has supported 36 MCCC investigators, accounting for more than 50% of the Shared Resource's total usage, and offered 22 classes and training programs attended by more than 40 MCCC investigators and personnel.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA015083-39
Application #
8465664
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-03-01
Budget End
2014-02-28
Support Year
39
Fiscal Year
2013
Total Cost
$226,952
Indirect Cost
$69,834
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
006471700
City
Rochester
State
MN
Country
United States
Zip Code
55905
Navari, Rudolph M; Qin, Rui; Ruddy, Kathryn J et al. (2016) Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting. N Engl J Med 375:134-42
Amirian, E Susan; Zhou, Renke; Wrensch, Margaret R et al. (2016) Approaching a Scientific Consensus on the Association between Allergies and Glioma Risk: A Report from the Glioma International Case-Control Study. Cancer Epidemiol Biomarkers Prev 25:282-90
Basch, Ethan; Rogak, Lauren J; Dueck, Amylou C (2016) Methods for Implementing and Reporting Patient-reported Outcome (PRO) Measures of Symptomatic Adverse Events in Cancer Clinical Trials. Clin Ther 38:821-30
Renner, Danielle N; Malo, Courtney S; Jin, Fang et al. (2016) Improved Treatment Efficacy of Antiangiogenic Therapy when Combined with Picornavirus Vaccination in the GL261 Glioma Model. Neurotherapeutics 13:226-36
McCormack, Valerie A; Burton, Anya; dos-Santos-Silva, Isabel et al. (2016) International Consortium on Mammographic Density: Methodology and population diversity captured across 22 countries. Cancer Epidemiol 40:141-51
Basal, E; Ayeni, T; Zhang, Q et al. (2016) Patterns of Müllerian Inhibiting Substance Type II and Candidate Type I Receptors in Epithelial Ovarian Cancer. Curr Mol Med 16:222-31
Cuellar-Partida, Gabriel; Lu, Yi; Dixon, Suzanne C et al. (2016) Assessing the genetic architecture of epithelial ovarian cancer histological subtypes. Hum Genet 135:741-56
Ye, Zi; Austin, Erin; Schaid, Daniel J et al. (2016) A multi-locus genetic risk score for abdominal aortic aneurysm. Atherosclerosis 246:274-9
Movsas, Benjamin; Hu, Chen; Sloan, Jeffrey et al. (2016) Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical Trial. JAMA Oncol 2:359-67
Kenkre, Vaishalee P; Hong, Fangxin; Cerhan, James R et al. (2016) Fc Gamma Receptor 3A and 2A Polymorphisms Do Not Predict Response to Rituximab in Follicular Lymphoma. Clin Cancer Res 22:821-6

Showing the most recent 10 out of 948 publications